Cardiovascular risk screening in China more than 700 thousand   high risk population — the low proportion of antiplatelet Health Channel – original title: cardiovascular risk screening in China more than 700 thousand people in high-risk groups by the national health program, the low proportion of the antiplatelet research center of medical science and Technology Development Planning Commission launched the cardiovascular risk screening program before the date announced in Beijing progress report. According to statistics, in the project has been screened in about 700000 patients, high-risk groups of antiplatelet drug use rate was significantly lower. Peking University People’s Hospital Heart Center Deputy Director Sun Ningling introduction, the cardiovascular risk screening program started in May 2015, as of September 2016, has covered 542 hospitals, held more than and 400 doctors will learn. The screening results showed that hypertensive patients over the age of 50, more than 90% associated with at least one risk factors, such as smoking, family history of cardiovascular disease, diabetes, hyperlipidemia, obesity etc.. The more risk factors, the more harm to health. Sun Ningling introduction, the use of anti platelet therapy in patients with high risk of cardiovascular disease, is one of the important means to prevent cardiovascular events, reduce mortality. But the screening results showed that in high risk population with no previous history of cardiovascular disease, antiplatelet drug use rate of less than 40%; in over 50 years of age and hypertension with at least 1 risk factors in patients with antiplatelet therapy was only 37%. In view of this situation, the affiliated An Zhen Hospital of Capital Medical University Department of epidemiology research director Zhao Dong pointed out that the key to good cardiovascular disease prevention is the risk stratification of high-risk population by locking, risk factor screening, targeted to take preventive measures. "The age of menopause for men aged over 45 or over the age of 55 women, if there is high blood pressure, high cholesterol, diabetes, family history of cardiovascular disease, obesity and smoking in three or more of the risk factors, is a higher risk of cardiovascular risk, requires the use of antiplatelet drugs under the guidance of professional doctors." Zhao Dong said. (Xinhua Beijing October 7th news (reporter Hu Hao): Juan Xu Xinyi, commissioning editor right)相关的主题文章: